Atossa Therapeutics, Inc. Email Format
Biotechnology ResearchUnited States51-200 Employees
Atossa Genetics Inc. (NASDAQ: ATOS) is developing locally-administered pharmaceuticals for pre-cancerous breast conditions and early stage breast cancer.
| Atossa Therapeutics, Inc. Email Formats | Percentage |
| First.Last@atossagenetics.com | 46% |
| Last@atossagenetics.com | 5% |
| First@atossagenetics.com | 3% |
| First.Last@atossagenetics.com | 46% |
Biotechnology ResearchUnited States51-200 Employees
Atossa Genetics Inc. (NASDAQ: ATOS) is developing locally-administered pharmaceuticals for pre-cancerous breast conditions and early stage breast cancer.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.